The 5-hydroxy group is reacted with a reagent like epichlorohydrin to introduce a side chain, which is then converted into the final 3-tert-butylamino-2-hydroxypropoxy group. 3,4-Dihydro-5-hydroxy-2(1H)-quinolinone serves as a key core building block for synthesizing Carteolol, a non-selective beta-adrenergic blocker used in glaucoma treatment.
3,4-Dihydro-5-hydroxy-2(1H)-quinolinone
| API Name | Carteolol |
|---|---|
| CAS No | 30389-33-4 |
| Molecular Formula | C9H9NO2 |
| Molecular Weight | 163.17 g/mol |
| Synonyms | 5-hydroxy-3,4-dihydro-1H-quinolin-2-one |
Zoho Contact Form - Pharma Intermediates
"*" indicates required fields
Frequently Asked Questions
The 5-hydroxy group is reacted with a reagent like epichlorohydrin to introduce a side chain, which is then converted into the final 3-tert-butylamino-2-hydroxypropoxy group. 3,4-Dihydro-5-hydroxy-2(1H)-quinolinone serves as a key core building block for synthesizing Carteolol, a non-selective beta-adrenergic blocker used in glaucoma treatment.
The CAS number of 3,4-Dihydro-5-hydroxy-2(1H)-quinolinone is 30389-33-4.
The molecular formula of 3,4-Dihydro-5-hydroxy-2(1H)-quinolinone is C9H9NO2.
The listed molecular weight of 3,4-Dihydro-5-hydroxy-2(1H)-quinolinone is 163.17 g/mol.
3,4-Dihydro-5-hydroxy-2(1H)-quinolinone is listed as being used in connection with the following API: Carteolol.
The listed synonym or IUPAC name for 3,4-Dihydro-5-hydroxy-2(1H)-quinolinone is 5-hydroxy-3,4-dihydro-1H-quinolin-2-one.